USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NOVAFLUX TECHNOLOGIES, INC.
Address:
1 WALL ST
PRINCETON, NJ
Phone:
N/A
URL:
N/A
EIN:
222907961
DUNS:
943652065
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $3,612,183.00 13
SBIR Phase II $8,489,297.00 8

Award List:

IMPROVED TECHNOLOGY FOR REPROCESSING HEMODIALYZERS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
Not Available Multimedia applications will be a major part of the rework traffic in the next generation of high speed networks. The cornerstone for multimedia is Asynchronous Transfer Mode (ATE, foreseen as the technology of the future Broadband Integrated Services Digital Network (13-ISDN).… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$374,860.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$132,193.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

Improved Technology for Reprocessing Hemodialyzers

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

Improved Technology for Reprocessing Hemodialyzers

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$390,508.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
N/a

NOVEL TECHNOLOGY FOR REPROCESSING FLEXIBLE ENDOSCOPES

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (Provided by applicant): The cleaning of narrow internal channels of flexible endoscopes with liquids at low flow velocities is inadequate because of a fundamental limitation of fluid dynamics. To achieve efficient cleaning, sufficient turbulence and high shear stresses must be applied… More

Environmentally Safe Polymeric Wood Preservatives

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$80,000.00
Agency:
USDA
Principal Investigator:
Abstract:
Environmentally safe wood preservatives based on polybiguanides (PBGs) chemistry will be developed. Building on our preliminary data, the novel PBG molecular structure will be tailored to possess multiple functions (anti-fungal), insecticidal, ion-chelating and hydrophobicity) to perform as a broad… More

Environmentally Safe Polymeric Wood Preservatives

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$0.00
Agency:
USDA
Principal Investigator:
Abstract:
NON-TECHNICAL SUMMARY: The results of the Phase I study demonstrated that modified polybiguanide (PBG) compounds have the ability to significantly protect wood against fungal decay according to the soil block standard at treatment concentrations below 1% without toxic heavy metal ions. Phase I… More

Environmentally Safe Polymeric Wood Preservatives

Award Year / Program / Phase:
2003 / SBIR / Phase II
Award Amount:
$296,000.00
Agency:
USDA
Principal Investigator:
Abstract:
NON-TECHNICAL SUMMARY: The results of the Phase I study demonstrated that modified polybiguanide (PBG) compounds have the ability to significantly protect wood against fungal decay according to the soil block standard at treatment concentrations below 1% without toxic heavy metal ions. Phase I… More

Device for Eradicting & Controlling Biofilm in Dialysis

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$138,544.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Hemodialysis is a water intensive therapy that presents an enormous challenge to cost effectively produce very large amounts of high purity water. The occurrence of bacteria and endotoxins in dialysis fluids is traced to biofilm that grows at surfaces in… More

Low Temp Decontamination/Sterilize/Dental Handpieces

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION: (provided by the applicant) Frequent repair and replacement of dental handpieces (DHs) represent major dental practice costs necessitating an immediate technological solution. Dental handpiece (DH) failure is primarily caused by the combined effects of poor cleaning of internal channels… More

Low Temp Decontamination/Sterilize/Dental Handpieces

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$786,406.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION: (provided by the applicant) Frequent repair and replacement of dental handpieces (DHs) represent major dental practice costs necessitating an immediate technological solution. Dental handpiece (DH) failure is primarily caused by the combined effects of poor cleaning of internal channels… More

Device for Eradicating /Controlling Biofilm in Dialysis

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$1,099,408.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in hemodialysis patients due to exposure to endotoxins has become a central issue in nephrology in recent years. The European Renal Association urges the routine use of ultrapure dialysate with… More

Novel Technology for Reprocessing Flexible Endoscopes

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$2,302,822.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
DESCRIPTION (provided by applicant): Since inadequate cleaning is the main cause of failure in sterilizing flexible endoscopes, cardinal modification of existing cleaning methods is urgently needed. During the Phase I (Grant # 1R43DK58622-01) and Phase II (Grant # 2R44DK58622-02) studies, Novaflux… More

Biofilm polymicrobial infection-resistant implants for otologic application

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$161,470.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics is prescribed for acute otitis media in the United States. Myringotomy with tympanostomy tube insertion has become the treatment of choice for children with chronic otitis media, with more than two million tubes sold… More

Novel biofilm polymicrobial infection-resistant implants for otologic application

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,239,295.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib
Abstract:
DESCRIPTION (provided by applicant): Over one-quarter of all oral antibiotics prescribed in the United States are for acute otitis media. Tympanostomy tube (TT) insertion has become the treatment of choice for children with recurrent or chronic otitis medi a, with more than two million tubes sold… More

A Novel Device for Managing Hypervolemia in CHF Patients

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$599,978.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): We discovered a new modality that will allow us to effectively remove excess fluid from patients and manage hypervolemia. Accordingly, we propose the development of a simple, safe miniature portable device that can slow ly remove sufficient excess fluid, on a… More

Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$2,299,998.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib – 609-683-0215
Abstract:
DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin… More

Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,999,998.00
Agency:
HHS
Principal Investigator:
Mohamed E. Labib – 609-683-0215
Abstract:
DESCRIPTION (provided by applicant): The clinical significance of chronic pro-inflammatory reactions in dialysis patients due to exposure to endotoxin has become a central issue in nephrology. The European Renal Association urges the routine use of ultrapure dialysate with bacteria and endotoxin… More